U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7170171701[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01627405
7170271702Mechanisms of the Nicotine Metabolism Effect on Tobacco DependenceRecruitingNo Results AvailableCigarette SmokingBehavioral: Smoking abstinencehttps://ClinicalTrials.gov/show/NCT01627392
7170371703Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell CancerActive, not recruitingNo Results AvailableEsophageal Squamous Cell CancerDrug: Cisplatin, 5-FU|Drug: Panitumumabhttps://ClinicalTrials.gov/show/NCT01627379
7170471704Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer SurvivorsActive, not recruitingNo Results AvailableBreast CancerOther: Survivorship Care Planhttps://ClinicalTrials.gov/show/NCT01627366
7170571705Post Hysterectomy Pain Prevention: Pre-op Wound Infiltration With Anesthetic Protocol Versus Standard of CareTerminatedNo Results AvailableHysterectomyProcedure: Standard of care|Procedure: Pre-emptive wound infiltrationhttps://ClinicalTrials.gov/show/NCT01627353
7170671706Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerixâ„¢-B in Adults With or Without Type 2 Diabetes MellitusCompletedHas ResultsHepatitis BBiological: Engerixâ„¢-B vaccinehttps://ClinicalTrials.gov/show/NCT01627340
7170771707Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk forCompletedHas ResultsPulmonary Disease, Chronic ObstructiveDrug: fluticasone furoate/vilanterol 100/25mcg|Drug: tiotropium bromide 18mcghttps://ClinicalTrials.gov/show/NCT01627327
7170871708The PUMA Trial is a Trial of a Single ProHema Modulated-CB Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.RecruitingNo Results AvailableHematologic MalignanciesBiological: ProHema-CB|Biological: Untreated CBhttps://ClinicalTrials.gov/show/NCT01627314
7170971709Sympathetic Overactivity in Post-traumatic Stress DisorderRecruitingNo Results AvailablePost-traumatic Stress Disorder|PrehypertensionDevice: Device-Guided Breathing using the RESPeRATE devicehttps://ClinicalTrials.gov/show/NCT01627301
7171071710Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)RecruitingNo Results AvailableCancer of the Cervix|Cervical NeoplasmsRadiation: Boost radiationhttps://ClinicalTrials.gov/show/NCT01627288
7171171711Naive T-Cell Depleted DLI Following Allo Stem Cell TransplantRecruitingNo Results AvailableHematological MalignanciesBiological: Naive T Cell Depleted Donor Lymphocyte Infusionhttps://ClinicalTrials.gov/show/NCT01627275
7171271712Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled StudyCompletedNo Results AvailableColonic DiverticulosisDrug: Mesalamine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01627262
7171371713Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for DMEActive, not recruitingNo Results AvailableDiabetic Macular EdemaDrug: 2.0 mg intravitreal aflibercept|Drug: 1.25 mg intravitreal bevacizumab|Drug: 0.3 mg intravitreal ranibizumabhttps://ClinicalTrials.gov/show/NCT01627249
7171471714Efficacy of Short-term Immunosuppressive Therapy and Anti-allergenic Therapy in Severe Acute Exacerbation of Chronic Hepatitis BRecruitingNo Results AvailableSevere Acute Exacerbation of Chronic Hepatitis BDrug: methylprednisolonehttps://ClinicalTrials.gov/show/NCT01627236
7171571715Comparison Between Lamivudine and Entecavir Treatment in PatientsRecruitingNo Results AvailableChronic Hepatitis BDrug: Lamivudine|Drug: Entecavirhttps://ClinicalTrials.gov/show/NCT01627223
7171671716Evaluation of Glycemic Control Using Adjunctive Continuous Glucose Monitoring With the Dexcom G4 SystemCompletedNo Results AvailableDiabetes Mellitushttps://ClinicalTrials.gov/show/NCT01627210
7171771717Adjuvant Intraarterial Chemotherapy Following Surgery to Treat Locally Advanced Bladder CancerEnrolling by invitationNo Results AvailableBladder CancerProcedure: Surgery of percutaneous catheter systemhttps://ClinicalTrials.gov/show/NCT01627197
7171871718Long-term Use: CGM System Assessment in Adult Athletes With Diabetes MellitusCompletedNo Results AvailableDiabetes MellitusDevice: Dexcom G4 CGM Systemhttps://ClinicalTrials.gov/show/NCT01627184
7171971719Colonoscopy Preparation Optimization for INpatients- COIN StudyRecruitingNo Results AvailableEndoscopy|Bowel Preparation SolutionsDrug: Bisacodyl 10mg|Drug: Polyethelene Glycol|Drug: Picosulfate sodiumhttps://ClinicalTrials.gov/show/NCT01627171
7172071720Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler ForteCompletedNo Results AvailableAsthmaDrug: Budesonide/formoterol Easyhaler|Drug: Symbicort Turbuhaler|Drug: Charcoal and Budesonide/formoterol Easyhaler|Drug: Charcoal and Symbicort Turbuhalerhttps://ClinicalTrials.gov/show/NCT01627158
7172171721Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic DrugRecruitingNo Results AvailableOveractive Bladder SyndromeDrug: Solifenacinhttps://ClinicalTrials.gov/show/NCT01627145
7172271722Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop TrialRecruitingNo Results AvailableChronic Myeloid LeukemiaDrug: Dasatinibhttps://ClinicalTrials.gov/show/NCT01627132
7172371723The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric CancerRecruitingNo Results AvailableGastric Cancerhttps://ClinicalTrials.gov/show/NCT01627119
7172471724A Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation (AF) (MK-6621-055)WithdrawnNo Results AvailableAtrial FibrillationDrug: Vernakalant|Drug: Amiodaronehttps://ClinicalTrials.gov/show/NCT01627106
7172571725Proton Therapy for Head and Neck MalignanciesRecruitingNo Results AvailableHead and Neck CancerOther: Chart Review|Behavioral: Questionnaireshttps://ClinicalTrials.gov/show/NCT01627093
7172671726Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and RadiationWithdrawnNo Results AvailableEsophageal CancerOther: Cardiac Biomarker Blood Drawshttps://ClinicalTrials.gov/show/NCT01627080
7172771727Exemestane-RAD001-MetforminActive, not recruitingNo Results AvailableBreast CancerDrug: Everolimus|Drug: Exemestane|Drug: Metforminhttps://ClinicalTrials.gov/show/NCT01627067
7172871728A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic LeukemiaCompletedNo Results AvailableChronic Lymphocytic LeukemiaDrug: AT7519Mhttps://ClinicalTrials.gov/show/NCT01627054
7172971729Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid LeukemiaRecruitingNo Results AvailableAdult Acute Basophilic Leukemia|Adult Acute Eosinophilic Leukemia|Adult Acute Monoblastic Leukemia|Adult Acute Monocytic Leukemia|Adult Acute Myeloid Leukemia With Maturation|Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL|Adult Acute MyeloiDrug: Cytarabine|Drug: Daunorubicin Hydrochloride|Drug: Decitabine|Other: Laboratory Biomarker Analysis|Other: Pharmacological Studyhttps://ClinicalTrials.gov/show/NCT01627041
7173071730Thai Traditional Massage Increases Biochemical Marker of Bone Formation in Postmenopausal WomenCompletedNo Results AvailableOsteoporosisProcedure: Thai traditional massagehttps://ClinicalTrials.gov/show/NCT01627028

* Görseller ve İçerik tekif hakkına sahip olabilir